Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients.
Am J Transplant. 2021 Nov;21(11):3714-3724. doi: 10.1111/ajt.16695. Epub 2021 Jun 23.
Am J Transplant. 2021.
PMID: 34033222
Clinical Trial.